(R)-Methyl 4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
98%
- Product Code: 230141
CAS:
10538-59-7
Molecular Weight: | 404.58 g./mol | Molecular Formula: | C₂₅H₄₀O₄ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | 107-109°C | Boiling Point: | |
Density: | Storage Condition: | Room temperature, dry |
Product Description:
Used in the synthesis of steroidal compounds, particularly as an intermediate in the preparation of active pharmaceutical ingredients involving modified steroid frameworks. Its functional groups and chiral centers make it valuable in developing drugs targeting hormonal and metabolic pathways. Commonly applied in research settings for structure-activity relationship studies of steroid-based therapeutics.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
250mg | 10-20 days | $19.45 |
+
-
|
1g | 10-20 days | $51.86 |
+
-
|
5g | 10-20 days | $97.67 |
+
-
|
25g | 10-20 days | $290.84 |
+
-
|
100g | 10-20 days | $607.60 |
+
-
|
(R)-Methyl 4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
Used in the synthesis of steroidal compounds, particularly as an intermediate in the preparation of active pharmaceutical ingredients involving modified steroid frameworks. Its functional groups and chiral centers make it valuable in developing drugs targeting hormonal and metabolic pathways. Commonly applied in research settings for structure-activity relationship studies of steroid-based therapeutics.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :